A Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis: a Topical Chemoprevention Strategy for Cutaneous T-cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2013
At a glance
- Drugs Bexarotene (Primary)
- Indications Cutaneous T cell lymphoma; Parapsoriasis
- Focus Therapeutic Use
- 25 Apr 2013 New trial record